Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): A phase 3 open-label randomised study

  1. Cortes, J.
  2. O'Shaughnessy, J.
  3. Loesch, D.
  4. Blum, J.L.
  5. Vahdat, L.T.
  6. Petrakova, K.
  7. Chollet, P.
  8. Manikas, A.
  9. Diéras, V.
  10. Delozier, T.
  11. Vladimirov, V.
  12. Cardoso, F.
  13. Koh, H.
  14. Bougnoux, P.
  15. Dutcus, C.E.
  16. Seegobin, S.
  17. Mir, D.
  18. Meneses, N.
  19. Wanders, J.
  20. Twelves, C.
Aldizkaria:
The Lancet

ISSN: 0140-6736

Argitalpen urtea: 2011

Alea: 377

Zenbakia: 9769

Orrialdeak: 914-923

Mota: Artikulua

DOI: 10.1016/S0140-6736(11)60070-6 GOOGLE SCHOLAR